LEADER 02183nam  2200625Ia 450 
001 9910778629803321
005 20230228230921.0
010   $a0-309-18353-7
010   $a1-280-18551-1
010   $a9786610185511
010   $a0-309-56964-8
035   $a(CKB)110986584753042
035   $a(SSID)ssj0000560440
035   $a(PQKBManifestationID)12226016
035   $a(PQKBTitleCode)TC0000560440
035   $a(PQKBWorkID)10571320
035   $a(PQKB)10335542
035   $a(MiAaPQ)EBC3377503
035   $a(Au-PeEL)EBL3377503
035   $a(CaPaEBR)ebr10071535
035   $a(CaONFJC)MIL18551
035   $a(OCoLC)697624774
035   $a(EXLCZ)99110986584753042
100   $a20001207d2000      ua             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aDescription and analysis of the VA National Formulary /$fDavid Blumenthal and Roger Herdman, editors ; VA Pharmacy Formulary Analysis Committee, Division of Health Care Services, Institute of Medicine
210  1$aWashington, D.C. :$cNational Academy Press,$d2000.
215   $axvi, 262 pages $cillustrations
300   $aBibliographic Level Mode of Issuance: Monograph
311 0 $a0-309-07365-0 
311 0 $a0-309-06986-6 
320   $aIncludes bibliographical references (p. 201-216).
606   $aDrugs$zUnited States
606   $aDrug utilization$xGovernment policy$zUnited States
606   $aMedicine$vFormulae, receipts, prescriptions
606   $aVeterans$xMedical care$zUnited States$xQuality control
615  0$aDrugs
615  0$aDrug utilization$xGovernment policy
615  0$aMedicine
615  0$aVeterans$xMedical care$xQuality control.
701   $aBlumenthal$b David$f1948-$01491262
701   $aHerdman$b Roger$01485067
712 02$aUnited States.$bDepartment of Veterans Affairs.
712 02$aInstitute of Medicine (U.S.)
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910778629803321
996   $aDescription and analysis of the VA National Formulary$93763634
997   $aUNINA